The path to precision medicine for MS, from AI to patient recruitment: an interview with Mauricio Farez and Helen Onuorah
This year’s World Brain Day is focused on stopping Multiple Sclerosis (MS). Although amazing progress has resulted in the development of relatively successful MS therapies, access to such therapies is a major problem for most of the world. In addition, major advances are still needed that would enab...
Guardado en:
| Formato: | article |
|---|---|
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/3db8ce94b7bb455989496bd841a94004 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | This year’s World Brain Day is focused on stopping Multiple Sclerosis (MS). Although amazing progress has resulted in the development of relatively successful MS therapies, access to such therapies is a major problem for most of the world. In addition, major advances are still needed that would enable more precise treatment of MS for all patient demographics. We therefore spoke to Dr Maurico Farez, whose pioneering work focuses on the use of AI for precision medicine in MS and Helen Onourah, who has highlighted crucial issues surrounding the inequities that exist in MS research. |
|---|